Narani Krishan Kumar
Department of Anaesthesiology, Pain and Perioperative Medicine, Sir Ganga Ram Hospital, New Delhi - 110 060, India.
Indian J Anaesth. 2010 Jan;54(1):8-17. doi: 10.4103/0019-5049.60490.
There is high incidence of venous thromboembolism, comprising of deep vein thrombosis and pulmonary embolism, in hospitalized patients. The need for systemic thromboprophylaxis is essential, especially in patients with inherited or acquired patient-specific risk factors or in patients undergoing surgeries associated with high incidence of postoperative deep vein thrombosis and pulmonary embolism. These patients, on prophylactic or therapeutic doses of anticoagulants, may present for surgery. General or regional anaesthesia may be considered depending on the type and urgency of surgery and degree of anticoagulation as judged by investigations. The dilemma regarding the type of anaesthesia can be solved if the anaesthesiologist is aware of the pharmacokinetics of drugs affecting haemostasis. The anaesthesiologist must keep abreast with the latest developments of methods and drugs used in the prevention and management of venous thromboembolism and their implications in the conduct of anaesthesia.
住院患者静脉血栓栓塞(包括深静脉血栓形成和肺栓塞)的发生率很高。进行全身性血栓预防至关重要,尤其是对于具有遗传性或获得性特定患者风险因素的患者,或接受与术后深静脉血栓形成和肺栓塞高发生率相关手术的患者。这些正在接受预防性或治疗性抗凝剂量治疗的患者可能需要进行手术。根据手术类型和紧迫性以及检查判断的抗凝程度,可考虑采用全身麻醉或区域麻醉。如果麻醉医生了解影响止血的药物的药代动力学,那么关于麻醉类型的困境就可以得到解决。麻醉医生必须紧跟预防和管理静脉血栓栓塞所使用的方法和药物的最新进展及其在麻醉实施中的影响。